StockNews.AI
WOK
StockNews.AI
3 hrs

Univest Securities, LLC Announces Closing of $2.9 Million Registered Direct Offering for its Client WORK Medical Technology Group LTD (NASDAQ: WOK)

1. WOK completed a $2.9 million registered direct offering. 2. 38,999,334 shares were sold at $0.075 per share. 3. The offering is part of a shelf registration effective since September 15, 2025. 4. WOK is a supplier of medical devices in China and the U.S. 5. The company has a diverse product portfolio sold internationally.

7m saved
Insight
Article

FAQ

Why Bullish?

The $2.9 million raise improves liquidity for WOK. Previous capital raises often correlate with stock price increases, suggesting positive sentiment.

How important is it?

The capital raise directly benefits WOK's operations and can support future growth, making it highly pertinent for investors.

Why Short Term?

Investors typically react quickly to capital raises. Historical trends show price movements often occur shortly after funding announcements.

Related Companies

NASDAQ: WOKNASDAQ: NDAQNYSE: UNVC
New York, Sept. 26, 2025 (GLOBE NEWSWIRE) -- Univest Securities, LLC (“Univest”), a member of FINRA and SIPC, and a full-service investment bank and securities broker-dealer firm based in New York, today announced the closing of $2.9 million registered direct offering (the “Offering”) for its client WORK Medical Technology Group LTD (NASDAQ: WOK) (the “Company”), a supplier of medical devices in China. Under the terms of the securities purchase agreement, the Company has agreed to sell to several investors 38,999,334 of the Company’s Class A ordinary share, par value $0.0005 per share (the “Shares”) (or pre-funded warrants in lieu thereof) at a purchase price of $0.075 per share in a registered direct offering. The purchase price for the pre-funded warrants is identical to the purchase price for Shares, less the exercise price of $0.0005 per share. The gross proceeds to the Company of the Offering were approximately $2.9 million. Univest Securities LLC acted as the sole placement agent. The registered direct offering was made pursuant to a shelf registration statement on Form F-3 (File No. 333-289943) previously filed by the Company and declared effective by the U.S. Securities and Exchange Commission (“SEC”) on September 15, 2025. A final prospectus supplement and accompanying prospectus describing the terms of the proposed offering were filed with the SEC and are available on the SEC's website located at http://www.sec.gov. Electronic copies of the final prospectus supplement and the accompanying prospectus may be obtained by contacting Univest Securities, LLC at info@univest.us, or by calling +1 (212) 343-8888. This press release does not constitute an offer to sell or the solicitation of an offer to buy, nor will there be any sales of such securities in any jurisdiction in which such offer, solicitation or sale would be unlawful prior to registration or qualification under the securities laws of such jurisdiction. Copies of the prospectus supplement relating to the registered direct offering, together with the accompanying base prospectus, can be obtained at the SEC's website at www.sec.gov. About Univest Securities, LLC Registered with FINRA since 1994, Univest Securities, LLC provides a wide variety of financial services to its institutional and retail clients globally including brokerage and execution services, sales and trading, market making, investment banking and advisory, and wealth management. It strives to provide clients with value-add service and focuses on building long-term relationships with its clients. As a prominent name on Wall Street, Univest has successfully raised over $1.3 billion in capital for issuers across the globe since 2019 and has completed approximately 100 transactions spanning a wide array of investment banking services in various industries, including technology, life sciences, industrial, consumer goods, etc. For more information, please visit: https://www.univest.us/. About WORK Medical Technology Group LTD WORK Medical Technology Group LTD, through its subsidiary, Work (Hangzhou) Medical Treatment Equipment Co., Ltd. and its subsidiaries in China, is a supplier of medical devices that develops and manufactures Class I and II medical devices and sells Class I and II disposable medical devices through operating subsidiaries in China. The Company has a diverse product portfolio comprising 21 products, including customized and multifunctional masks and other medical consumables. All the products have been sold in 34 provincial-level administrative regions in China, with 15 of them sold in more than 30 countries worldwide. The Company has received a number of quality-related manufacturing designations and has registered 17 products with the U.S. Food and Drug Administration allowing their products to enter the U.S. market. For more information, please visit the Company’s website: https://www.workmedtech.com/corporate. Forward-Looking Statements This press release contains forward-looking statements as defined by the Private Securities Litigation Reform Act of 1995. Forward-looking statements include statements concerning plans, objectives, goals, strategies, future events or performance, and underlying assumptions and other statements that are other than statements of historical facts. When the Company uses words such as “may, “will, “intend,” “should,” “believe,” “expect,” “anticipate,” “project,” “estimate” or similar expressions that do not relate solely to historical matters, it is making forward-looking statements. Forward-looking statements are not guarantees of future performance and involve risks and uncertainties that may cause the actual results to differ materially from the Company’s expectations discussed in the forward-looking statements. These statements are subject to uncertainties and risks including, but not limited to, the uncertainties related to market conditions and the completion of the initial public offering on the anticipated terms or at all, and other factors discussed in the “Risk Factors” section of the registration statement filed with the SEC. For these reasons, among others, investors are cautioned not to place undue reliance upon any forward-looking statements in this press release. Additional factors are discussed in the Company’s filings with the SEC, which are available for review at www.sec.gov. Univest Securities LLC and the Company undertakes no obligation to publicly revise these forward-looking statements to reflect events or circumstances that arise after the date hereof. For more information, please contact: Univest Securities, LLCEdric GuoChief Executive Officer75 Rockefeller Plaza, Suite 18CNew York, NY 10019Phone: (212) 343-8888Email: info@univest.us

Related News